| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052488 | The Journal of Urology | 2005 | 5 Pages |
Abstract
To our knowledge this is the first study to evaluate change in warning time, which is potentially important to individuals with symptoms associated with overactive bladder. Darifenacin increases mean, median and minimum warning time compared with placebo, allowing subjects more time to reach a toilet and potentially avoiding the embarrassing experience of incontinence.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
LINDA CARDOZO, ANDREA DIXON,